Introduction
Proteus syndrome (PS) is a rare postnatal overgrowth disorder affecting multiple tissue including bone, soft-tissue, and skin. First described by Cohen and Heyden in 1979, [1, 2] Wiedemann et al. in 1983 given the name of "PS" to this distinct entity. [3] It is a complex hamartomatous condition characterized by partial gigantism of hands, feet or both, plantar hyperplasia, hemangiomas, lipomas, lymphangiomas, varicosities, verrucous epidermal nevi, macrocephaly; cranial exostosis, and asymmetry of the limbs because of long bone overgrowth. [4] Until recently approximately 200 cases of PS has been reported in literature. Only a few isolated cases have been reported from India. [5, 6] So we thought it would be relevant to report this case series as several aspects of this condition are important for pediatricians, as pediatricians are the first person to encounter such cases. Over a period of 3 years, six patients with Proteus and Proteus like syndromes were seen. Their clinical profile and disease characteristics are described.
Materials and Methods
Between January 2008 and December 2010, we retrospectively reviewed the case profile of nine patients who presented with localized over-growth and/or hemihypertrophy in the out-patient clinic of Genetic and profiles of each of these cases are presented in Table 1 .
Three patients had dysmorphic facies, one patient had strawberry hemangioma on face and one patient had lipoma over scapular area. Cerebriform connective tissue nevi (CCTN) were seen in two patients at palmar aspect.
Two patients had developmental delay; and among them magnetic resonance imaging (MRI) was suggestive of megalencephaly in one and lissencephaly in other (case 2 and 5, respectively) [ Table 1 ]. Sonography of abdomen for internal organ visceromegaly was done in all patients but visceromegaly or internal hemangiomas were not detected. 
Discussion
PS is a rare congenital disorder that produces multifocal over-growth of tissue. It may affect tissues derived from any of the three germinal layers. [1, 9] Hallmark of this disorder is the random or mosaic distribution of its manifestations throughout the body. Klippel-Trénaunay syndrome and Hemi hyperplasia-multiple lipomatosis syndromes are the entities most commonly confused with PS. [10] Other disorders like BWS, Banayan-Zonana, Neurofibromatosis type 1, encephalocraniocutaneous lipomatosis and M-CM syndrome also have similarities to PS. [11] During analysis of present series we also excluded three cases with alternate diagnoses.
Signs of this sporadic syndrome may include over-growth of the long bones, asymmetric macrocephaly, asymmetric over-growth, vertebral anomalies, hyperostosis, partial gigantism of hands or feet, limb asymmetry, connectivetissue nevi, lipomas, and vascular malformations. [2, 3, 10] Visceral anomalies such as splenomegaly, asymmetric megalencephaly, white-matter abnormalities, and nephromegaly, as well as malformations involving fatty, muscular, and vascular tissue are seen. [1, 4, 12] Diagnosis of PS was based on criteria provided by Biesecker et al. [1] General criteria were fulfilled by all cases in present series. Category A criteria was fulfilled by only two patients who had CCTN at palmar aspect.
CCTN is hall-mark of the disease, and it can occur on plantar surface of foot, palmar aspect of hand, or rarely on chest, abdomen, back, lateral and dorsal aspect of fingers, and on nose. [13, 14] Presence of single CCTN is sufficient for making diagnosis of PS. CCTN is never reported at birth, usually appears later in life and it is progressive throughout childhood.
Dermatological manifestations of PS as reported by
Beachkofsky et al., CCTN was present among 94% of their 36 patients. [14] Among category B, although epidermal nevus was not seen in any of our patients, pigmentation abnormality was present in all: Café-au-lait spots and areas of patchy hyperpigmentation with hypopigmentation. Strawberry hemangioma was present on face in one patient. Other dermatological manifestation reported are epidermal nevi, cutaneous vascular malformations including capillary, venous, lymphatic or combined malformation, lipoma, partial lipohypoplasia and patchy dermal hyperplasia. [14] Extracutaneous manifestations include skeletal and visceral over-growth, tumors, cyst, vascular abnormality, deformity, and hypoplasia or maldevelopment. All patients usually have disproportionate overgrowth of hands and feet and it may involve fingers and toes in the form of macrodactyly. Overgrowth in PS is not only disproportionate and asymmetric, but also progressive and distorting. [4, 14, 15] Four patients had hemihypertrophy and four had macrodactyly involving fingers as well as toes. In two patients, underlying bony overgrowths was also noticed in X-ray of the hand [ Figure 1b ].
Disproportionate overgrowth was present at birth in one patient and among rest it was observed in later life.
Abnormalities of bony cortex with deficiency of overlying soft tissue can be seen in radiograph. One girl in present series had hyperostosis on vertex of skull [ Figure 2 ]. [4, 7] Therefore, diagnosis is usually delayed until the lesions are fully expressed in later childhood or adolescence.
PS has been reported in discordant monozygotic twins. [15] Pathogenesis behind PS is a somatic mutation that is lethal when constitutively expressed. [4] A somatic mutation arises in a somatic cell and is thus present only in that cell and the lineages to which it gives rise, rather than being present in the conceptus and thus constitutively present in every cell of the body. [15] Management should be directed towards functional improvement. Patients with limb length discrepancy, joint immobility and macrodactyly are best managed by team consisting of pediatrician, orthopedic surgeon, plastic surgeon and occupational therapist.
Conclusion
PS is characterized by progressive mosaic over-growth of skin, bone, muscle, and fatty tissue. The variable signs of PS makes the diagnosis challenging. A multidisciplinary approach is needed with follow-up for detection and management of complications.
